We are live on ! Find out more
Rockefeller Capital Management

Rockefeller Capital Management Portfolio holdings

AUM $56.4B
1-Year Est. Return 24.96%
This Fund
S&P 500
This Quarter Est. Return
-0.57%
1 Year Est. Return
+24.96%
3 Year Est. Return
+83.53%
5 Year Est. Return
+100.91%
10 Year Est. Return
AUM
$19B
AUM Growth
+$1.28B
Cap. Flow
+$1.55B
Cap. Flow %
8.12%
Top 10 Hldgs %
20.03%
Holding
3,992
New
448
Increased
1,821
Reduced
816
Closed
180

Top Buys

Rank Stock Value
1
ELAN icon
Elanco Animal Health
ELAN
+$89.1M
2
WEX icon
WEX
WEX
+$78.4M
3
BLK icon
Blackrock
BLK
+$73.2M
4
VOO icon
Vanguard S&P 500 ETF
VOO
+$71.9M
5
OMF icon
OneMain Financial
OMF
+$45.3M

Sector Composition

Rank Sector Weight
1 Technology 20.39%
2 Financials 14.65%
3 Healthcare 12.11%
4 Consumer Discretionary 7.54%
5 Industrials 6.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ISEE
3251
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$4K ﹤0.01%
300
NYMX
3252
DELISTED
Nymox Pharmaceutical Corp
NYMX
$4K ﹤0.01%
2,000
VLTA.WS
3253
DELISTED
Volta Inc. Warrants, each whole warrant exercisable for one Class A Common Stock at an exercise price of $11.50 per share
VLTA.WS
$4K ﹤0.01%
+1,625
New +$3.75K
VTIQW
3254
DELISTED
VectoIQ Acquisition Corp. II Warrant
VTIQW
$4K ﹤0.01%
+5,300
New +$5.78K
HUGS.WS
3255
DELISTED
USHG Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
HUGS.WS
$4K ﹤0.01%
+4,999
New +$4.84K
FSRDW
3256
DELISTED
Fast Radius, Inc. Warrants
FSRDW
$4K ﹤0.01%
+5,250
New +$5.21K
TEN
3257
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
$4K ﹤0.01%
315
SPAK
3258
DELISTED
Defiance Next Gen SPAC Derived ETF
SPAK
$4K ﹤0.01%
200
RBAC
3259
DELISTED
RedBall Acquisition Corp.
RBAC
$4K ﹤0.01%
500
OCDX
3260
DELISTED
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
$4K ﹤0.01%
270
+250
+1,250% +$5.03K
SVSVW
3261
DELISTED
Spring Valley Acquisition Corp. Warrant
SVSVW
$4K ﹤0.01%
+6,000
New +$5.74K
FMBI
3262
DELISTED
First Midwest Bancorp Inc/IL
FMBI
$4K ﹤0.01%
225
-162
-42% -$2.98K
KL
3263
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
$4K ﹤0.01%
+100
New +$4.06K
XLRN
3264
DELISTED
Acceleron Pharma
XLRN
$4K ﹤0.01%
29
SCR
3265
DELISTED
Score Media and Gaming Inc. Class A Subordinate Voting Shares
SCR
$4K ﹤0.01%
129
FBC
3266
DELISTED
Flagstar Bancorp, Inc. New
FBC
$4K ﹤0.01%
98
+26
+36% +$1.23K
VZIO
3267
DELISTED
VIZIO Holding Corp.
VZIO
$4K ﹤0.01%
200
FM
3268
DELISTED
iShares Frontier and Select EM ETF
FM
$4K ﹤0.01%
131
-13
-9% -$436
VEDL
3269
DELISTED
Vedanta Limited American Depostary Shares (Each representing four equity shares)
VEDL
$4K ﹤0.01%
286
+206
+258% +$3.24K
ACMR icon
3270
ACM Research
ACMR
$5.79B
$3K ﹤0.01%
+93
New +$2.85K
ADTN icon
3271
Adtran
ADTN
$616M
$3K ﹤0.01%
172
ADUS icon
3272
Addus HomeCare
ADUS
$2.23B
$3K ﹤0.01%
+47
New +$4.08K
AMKR icon
3273
Amkor Technology
AMKR
$13.7B
$3K ﹤0.01%
+145
New +$3.7K
APOG icon
3274
Apogee Enterprises
APOG
$908M
$3K ﹤0.01%
+91
New +$3.65K
ASO icon
3275
Academy Sports + Outdoors
ASO
$2.98B
$3K ﹤0.01%
+96
New +$3.83K

Similar funds

Rockefeller Capital Management's Q3 2021 Portfolio in Review

As of Q3 2021, Rockefeller Capital Management held 3,992 positions worth $19B, up 7.2% from $17.8B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Rockefeller Capital Management deployed $1.55B of net new capital in Q3 2021, opening 448 new positions and adding to 1,821 existing holdings. Its largest new stake was Darling Ingredients: 56,725 shares worth $4.08M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Regeneron Pharmaceuticals, an estimated $63.6M trimmed.

  • Rockefeller Capital Management's largest Q3 2021 buy was Darling Ingredients: 56,725 shares worth $4.08M.
  • Rockefeller Capital Management added most to Elanco Animal Health in Q3 2021, an estimated $89.1M increase.
  • Rockefeller Capital Management's biggest Q3 2021 reduction was Regeneron Pharmaceuticals, cutting an estimated $63.6M.
  • Rockefeller Capital Management fully exited ORBCOMM, Inc. in Q3 2021, selling an estimated $27.5M.
  • Rockefeller Capital Management's ten largest holdings make up 20% of its $19B portfolio in Q3 2021.
  • Rockefeller Capital Management opened 448 new positions and closed 180 in Q3 2021.
  • Rockefeller Capital Management's portfolio value rose 7.2% quarter-over-quarter to $19B.

Based on Rockefeller Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.